Science
From Imatinib to CAR-T: 20 Years of Leukaemia Progress
Advances in leukaemia treatment have accelerated from first-generation chemotherapy to precision targets and cellular immunotherapy. In this article, we summarise a paper by Robert Peter Gale, published in the OncoDaily Medical Journal,…
